MabCure, Inc.
MBCI · OTC
12/31/2011 | 12/31/2010 | 12/31/2009 | 12/31/2008 | |
|---|---|---|---|---|
| Revenue | $500 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $500 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| R&D Expenses | $391 | $352 | $403 | $4 |
| G&A Expenses | $0 | $667 | $730 | $528 |
| SG&A Expenses | $819 | $667 | $940 | $528 |
| Sales & Mktg Exp. | $0 | $0 | $209 | $0 |
| Other Operating Expenses | $0 | $0 | $17 | $4 |
| Operating Expenses | $1,210 | $1,019 | $1,359 | $536 |
| Operating Income | -$710 | -$1,019 | -$1,359 | -$536 |
| % Margin | -141.9% | – | – | – |
| Other Income/Exp. Net | -$11,555 | -$206 | -$12 | $5 |
| Pre-Tax Income | -$12,265 | -$1,226 | -$1,372 | -$531 |
| Tax Expense | $187 | $207 | $17 | $1 |
| Net Income | -$12,451 | -$1,433 | -$1,389 | -$531 |
| % Margin | -2,490.3% | – | – | – |
| EPS | -0.2 | -0.023 | -0.023 | -0.012 |
| % Growth | -765.8% | -0.4% | -87% | – |
| EPS Diluted | -0.2 | -0.023 | -0.023 | -0.012 |
| Weighted Avg Shares Out | 63,715 | 62,055 | 60,357 | 43,098 |
| Weighted Avg Shares Out Dil | 63,715 | 62,055 | 60,357 | 43,098 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $4 | $6 |
| Interest Expense | $187 | $207 | $17 | $1 |
| Depreciation & Amortization | $33 | $44 | $45 | $10 |
| EBITDA | -$12,046 | -$976 | -$1,314 | -$526 |
| % Margin | -2,409.1% | – | – | – |